Evaluation of Early Prognostic Factors in Patients With Pancreatic Ductal Adenocarcinoma Receiving Gemcitabine Together With Nab-paclitaxel.
Cancer diagnosis & prognosis（2021）
摘要
These results may be useful for decision-making regarding treatment strategies in patients with PDAC receiving GnP.
更多查看译文
关键词
CA19-9 antigen,chemotherapy,nutrition status,paclitaxel,risk factors
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要